Nine pharmaceutical companies agree to most-favored-nation pricing

An additional nine of the world's largest pharmaceutical companies have agreed to offer many of their most popular drugs at most-favored-nation pricing in the U.S.

This means that the U.S. will pay the lowest price for many prescription drugs among its economic peers. The initiative has been a major priority for President Donald Trump, according to top Health and Human Services officials, as he has sought to reduce prescription drug prices for Americans.